Duration of second complete remission in patients with acute myeloid leukemia treated with chemotherapy: a retrospective single-center study
Florian Thalhammer, Klaus Lechner, O. A. Haas(Boston Children's Hospital), Margit Mitterbauer, Heinz Gisslinger(Medical University of Vienna), Paul A. Kyrle(Karl Landsteiner Society), Barbara Schneider(Altonaer Kinderkrankenhaus), Klaus Geißler(University of Vienna), Klaus Laczika(Austrian Atherosclerosis Society), Ingrid Pabinger(Medical University of Vienna), Paul Knöbl(Medical University of Vienna), Ulrich Jäger(Medical University of Vienna)
Cited by 53
Related Papers
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer
|Cell|2018|2.8k
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
|New England Journal of Medicine|2021|2.3k
von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome
|New England Journal of Medicine|1998|1.7k
High Plasma Levels of Factor VIII and the Risk of Recurrent Venous Thromboembolism
|New England Journal of Medicine|2000|765
Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas
|Cancer Cell|2018|718